5MG Tablets, USP 90 Count: 1219363M: Feb-2019: 0591 COZAAR is available as tablets for oral administration containing either 25 mg, 50 mg or 100 mg of losartan potassium and the following inactive ingredients: microcrystalline cellulose, lactose hydrous, pregelatinized starch, magnesium stearate, hydroxypropyl cellulose, hypromellose, and titanium dioxide
Losartan and Hydrochlorothiazide oral tablet, Rising Pharmaceuticals, 100 mg/ 12
To search archived content, visit Search FDA Archive and input the name of September 23, 2019
2019: The FDA releases a statement updating the public about the current state of the valsartan investigation
You may report side effects to FDA at 1-800-FDA-1088
Potential neonatal adverse effects include skull hypoplasia, anuria, hypotension, renal failure, and death